UnitedHealth Group Incorporated (UNH) Stake Reduced by American International Group Inc.
American International Group Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 20.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 299,482 shares of the healthcare conglomerate’s stock after selling 78,392 shares during the period. American International Group Inc.’s holdings in UnitedHealth Group were worth $49,118,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of the company. TRUE Private Wealth Advisors raised its position in shares of UnitedHealth Group by 11.4% in the first quarter. TRUE Private Wealth Advisors now owns 5,219 shares of the healthcare conglomerate’s stock worth $866,000 after buying an additional 533 shares during the period. Oakbrook Investments LLC increased its stake in UnitedHealth Group by 146.5% in the first quarter. Oakbrook Investments LLC now owns 41,775 shares of the healthcare conglomerate’s stock worth $6,852,000 after buying an additional 24,825 shares during the period. Johanson Financial Advisors Inc. purchased a new stake in UnitedHealth Group during the first quarter worth $1,068,000. Ledyard National Bank increased its stake in UnitedHealth Group by 62.7% in the first quarter. Ledyard National Bank now owns 1,103 shares of the healthcare conglomerate’s stock worth $181,000 after buying an additional 425 shares during the period. Finally, Quantitative Systematic Strategies LLC purchased a new stake in UnitedHealth Group during the first quarter worth $331,000. 86.21% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Incorporated (UNH) traded up 0.43% during midday trading on Friday, reaching $199.75. 2,242,195 shares of the company’s stock were exchanged. The company has a market cap of $193.13 billion, a price-to-earnings ratio of 24.00 and a beta of 0.63. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $199.99. The firm has a 50-day moving average price of $192.88 and a 200 day moving average price of $178.33.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the company earned $1.96 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s payout ratio is 35.13%.
A number of research firms have weighed in on UNH. Jefferies Group LLC restated a “buy” rating and issued a $192.00 target price on shares of UnitedHealth Group in a research report on Friday, May 19th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 target price for the company in a research report on Wednesday, June 7th. Barclays PLC upped their target price on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 19th. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Finally, Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, June 9th. One research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $203.41.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 25,000 shares of company stock valued at $4,758,750 in the last quarter. Corporate insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.